http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005101010-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2005-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b19e9441da08f9fcc91a2d148c9174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b9192f647409ae2db8f2c99d6e559d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a815d120d18a69d36ef9c4ce44e8b8 |
publicationDate | 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2005101010-A2 |
titleOfInvention | Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor gamma (pparg) |
abstract | The invention provides a human PPARG which is associated with the cardiovascular diseases, infections, respiratory diseases, endocrinological diseases, metabolic diseases, cancer, gastroenterological diseases, inflammation, hematological diseases, muscle skeleton disorders, neurological diseases and urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, infections, respiratory diseases, endocrinological diseases, metabolic diseases, cancer, gastroenterological diseases, inflammation, hematological diseases, muscle skeleton disorders, neurological diseases and urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of PPARG as well as pharmaceutical compositions comprising such compounds. |
priorityDate | 2004-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2314.